Processing

Please wait...

Settings

Settings

Goto Application

1. WO2006038988 - CHEWABLE ELECTROLYTE TABLET

Publication Number WO/2006/038988
Publication Date 13.04.2006
International Application No. PCT/US2005/028784
International Filing Date 15.08.2005
IPC
A61K 9/20 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
20Pills, lozenges or tablets
CPC
A61K 31/198
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
19Carboxylic acids, e.g. valproic acid
195having an amino group
197the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
198Alpha-aminoacids, e.g. alanine, edetic acids [EDTA],
A61K 31/405
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
40having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
403condensed with carbocyclic rings, e.g. carbazole
404Indoles, e.g. pindolol
405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
A61K 31/4172
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
41having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
41641,3-Diazoles
4172Imidazole-alkanecarboxylic acids, e.g. histidine
A61K 31/4188
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
41having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
41641,3-Diazoles
4188condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
A61K 9/0056
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
0012Galenical forms characterised by the site of application
0053Mouth and digestive tract, i.e. intraoral and peroral administration
0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
Applicants
  • PAL LABORATORIES, INC. [US]/[US] (AllExceptUS)
  • ROSS, Neil [US]/[US] (UsOnly)
  • REYMAN, Jerome [US]/[US] (UsOnly)
Inventors
  • ROSS, Neil
  • REYMAN, Jerome
Agents
  • PASSLER, Mark, D.
Priority Data
10/954,87430.09.2004US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) CHEWABLE ELECTROLYTE TABLET
(FR) COMPRIME ELECTROLYTIQUE A MACHER
Abstract
(EN)
A chewable electrolyte tablet. The chewable electrolyte tablet includes an agent to prevent stomach irritation, a flavoring agent, a sweetening agent, or a combination thereof to enable the tablet to be palatable and, therefore, ingested through simple mastication and without the need for water, thereby permitting the amount of water to be regulated. The tablet may be used to deliver electrolytes, amino acids and/or vitamins. Select embodiments of the tablet contain substantially no carbohydrates, thereby reducing the caloric content of the tablet. In other embodiments, the tablet provides a sustained release of nutrients over time.
(FR)
L'invention concerne un comprimé électrolytique à mâcher. Ce comprimé comprend un agent pour prévenir une irritation stomacale, un agent aromatisant, un agent édulcorant, ou une combinaison de ceux-ci pour rendre le comprimé sapide, et par conséquent, pour que ce comprimé soit ingéré par une simple mastication et sans qu'il soit nécessaire d'avoir recours à de l'eau, ce qui permet de réguler la quantité d'eau. Ce comprimé peut être utilisé pour administrer des électrolytes, des acides aminés et/ou des vitamines. Des modes de réalisation sélectionnés de ce comprimé ne contiennent sensiblement pas de glucides, ce qui permet de réduire la teneur en calories de ce comprimé. Dans d'autres modes de réalisation, ce comprimé permet une libération continue de nutriments pendant une période prolongée.
Also published as
Latest bibliographic data on file with the International Bureau